191 related articles for article (PubMed ID: 25479932)
1. [Immunization in children and adolescents with rheumatic and musculoskeletal diseases].
Minden K; Speth F; Huppertz HI; Borte M
Z Rheumatol; 2014 Dec; 73(10):878-89. PubMed ID: 25479932
[TBL] [Abstract][Full Text] [Related]
2. [Immunization in children and adolescents with rheumatic diseases].
Minden K; Niewerth M; Borte M; Singendonk W; Haas JP
Z Rheumatol; 2007 Mar; 66(2):111-2, 114-8, 120. PubMed ID: 17364157
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases: a systematic review of the literature.
Sousa S; Duarte AC; Cordeiro I; Ferreira J; Gonçalves MJ; Meirinhos T; Rocha TM; Romão VC; Santos MJ
Acta Reumatol Port; 2017; 42(1):8-16. PubMed ID: 28133957
[TBL] [Abstract][Full Text] [Related]
4. [Chronic and vaccine-preventable diseases in children and adolescents in Germany: results of the KiGGS study: first follow up (KiGGS wave 1)].
Neuhauser H; Poethko-Müller C;
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):779-88. PubMed ID: 24950827
[TBL] [Abstract][Full Text] [Related]
5. American College of Preventive Medicine practice policy statement: childhood immunizations.
Adetunji Y; Macklin D; Patel R; Kinsinger L
Am J Prev Med; 2003 Aug; 25(2):169-75. PubMed ID: 12880889
[TBL] [Abstract][Full Text] [Related]
6. Immunisation coverage annual report, 2013.
Hull BP; Dey A; Beard FH; Menzies RI; Brotherton JM; McIntyre PB
Commun Dis Intell Q Rep; 2016 Mar; 40(1):E146-69. PubMed ID: 27080022
[No Abstract] [Full Text] [Related]
7. Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan.
Baba K; Okuno Y; Tanaka-Taya K; Okabe N
Vaccine; 2011 Apr; 29(16):3089-92. PubMed ID: 20870055
[TBL] [Abstract][Full Text] [Related]
8. Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs.
Morel J; Czitrom SG; Mallick A; Sellam J; Sibilia J
Joint Bone Spine; 2016 Mar; 83(2):135-41. PubMed ID: 26453106
[TBL] [Abstract][Full Text] [Related]
9. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
[TBL] [Abstract][Full Text] [Related]
10. The impact of immunisation on childhood infections in Singapore.
Boon WH
J Singapore Paediatr Soc; 1979; 21(1-2):1-9. PubMed ID: 548629
[No Abstract] [Full Text] [Related]
11. Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections.
Singer NG; McCune WJ
Curr Opin Rheumatol; 1999 May; 11(3):173-8. PubMed ID: 10328575
[TBL] [Abstract][Full Text] [Related]
12. [The present status of prevalence of infections against which regular immunization is provided in the Czech Republic].
Kríz B; Cástková J; Srámová H; Benes C
Epidemiol Mikrobiol Imunol; 1995 Dec; 44(4):184-8. PubMed ID: 8556250
[No Abstract] [Full Text] [Related]
13. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000.
McIntyre P; Gidding H; Gilmour R; Lawrence G; Hull B; Horby P; Wang H; Andrews R; Burgess M;
Commun Dis Intell Q Rep; 2002 May; Suppl():i-xi, 1-111. PubMed ID: 12194422
[No Abstract] [Full Text] [Related]
14. Recommendations for Vaccination in Adult Patients with Systemic Inflammatory Rheumatic Diseases from the Portuguese Society of Rheumatology.
Cordeiro I; Duarte AC; Ferreira JF; Gonçalves MJ; Meirinhos T; Rocha TM; Romão VC; Sousa S; Guedes M; Conde M; Abreu C; Aleixo MJ; Santos MJ
Acta Reumatol Port; 2016; 41(2):112-30. PubMed ID: 27606471
[TBL] [Abstract][Full Text] [Related]
15. Childhood vaccinations and risk of acute lymphoblastic leukaemia in children.
Søegaard SH; Rostgaard K; Schmiegelow K; Kamper-Jørgensen M; Hargreave M; Hjalgrim H; Hviid A
Int J Epidemiol; 2017 Jun; 46(3):905-913. PubMed ID: 28431124
[TBL] [Abstract][Full Text] [Related]
16. [Carrying-out compulsory preventive vaccination in Poland in 1986].
Słońska Z; Janusik B
Przegl Epidemiol; 1988; 42(2 |||||||||||||):147-53. PubMed ID: 3231717
[No Abstract] [Full Text] [Related]
17. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
[TBL] [Abstract][Full Text] [Related]
18. 48th ICAAC/46th IDSA Annual Meeting: a pediatric perspective.
Ulloa-Gutierrez R; Soriano-Fallas A; Camacho-Badilla K; Arguedas A
Expert Rev Vaccines; 2009 Feb; 8(2):143-7. PubMed ID: 19196193
[TBL] [Abstract][Full Text] [Related]
19. Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations.
Di Pietro A; Visalli G; Antonuccio GM; Facciolà A
Ann Ig; 2019; 31(2 Supple 1):54-64. PubMed ID: 30994164
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
